Infections and CAR-T cells for the treatment of lymphoid malignancies: a narrative review
The use of chimeric antigen receptor-T (CAR-T) cells have revolutionized the therapeutic paradigm of patients with lymphoid malignancies. However, infectious complications represent a frequent CAR-T cell-related adverse event, potentially being a major hurdle for the successful outcome of the patien...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2026-06-01
|
| シリーズ: | Frontiers in Medicine |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fmed.2026.1830105/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|